CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2023		105,209,000
Balance at beginning of period at Dec. 31, 2023	$ 1,588,351	$ 105	$ 1,354,703	$ (32,626)	$ 266,169
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	63,701				63,701
Other comprehensive income (loss)	(11,379)			(11,379)
Dividends declared	(56,382)				(56,382)
Net issuances of restricted stock (in shares)		751,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	16,777		16,777
Repurchases of common stock (in shares)		(1,028,000)
Repurchases of common stock	(81,823)	$ (1)			(81,822)
Balance at ending of period (in shares) at Mar. 31, 2024		104,932,000
Balance at end of period at Mar. 31, 2024	1,519,245	$ 105	1,371,479	(44,005)	191,666
Balance at beginning of period (in shares) at Dec. 31, 2023		105,209,000
Balance at beginning of period at Dec. 31, 2023	1,588,351	$ 105	1,354,703	(32,626)	266,169
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	131,857
Other comprehensive income (loss)	(17,965)
Balance at ending of period (in shares) at Jun. 30, 2024		104,056,000
Balance at end of period at Jun. 30, 2024	1,480,155	$ 104	1,387,110	(50,591)	143,532
Balance at beginning of period (in shares) at Mar. 31, 2024		104,932,000
Balance at beginning of period at Mar. 31, 2024	1,519,245	$ 105	1,371,479	(44,005)	191,666
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	68,156				68,156
Other comprehensive income (loss)	(6,586)			(6,586)
Dividends declared	(55,407)				(55,407)
Net issuances of restricted stock (in shares)		27,000
Stock-based compensation	15,631		15,631
Repurchases of common stock (in shares)		(903,000)
Repurchases of common stock	(60,884)	$ (1)			(60,883)
Balance at ending of period (in shares) at Jun. 30, 2024		104,056,000
Balance at end of period at Jun. 30, 2024	$ 1,480,155	$ 104	1,387,110	(50,591)	143,532
Balance at beginning of period (in shares) at Dec. 31, 2024	102,199,470	102,199,000
Balance at beginning of period at Dec. 31, 2024	$ 1,378,003	$ 102	1,418,150	(65,138)	24,889
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	17,350				17,350
Other comprehensive income (loss)	11,472			11,472
Dividends declared	(60,163)		(60,163)
Net issuances of restricted stock (in shares)		823,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	16,705		16,705
Repurchases of common stock (in shares)		(858,000)
Repurchases of common stock	(50,145)	$ (1)	(7,905)		(42,239)
Balance at ending of period (in shares) at Mar. 31, 2025		102,164,000
Balance at end of period at Mar. 31, 2025	$ 1,313,222	$ 102	1,366,786	(53,666)	0
Balance at beginning of period (in shares) at Dec. 31, 2024	102,199,470	102,199,000
Balance at beginning of period at Dec. 31, 2024	$ 1,378,003	$ 102	1,418,150	(65,138)	24,889
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	58,318
Other comprehensive income (loss)	$ 35,111
Balance at ending of period (in shares) at Jun. 30, 2025	101,738,661	101,739,000
Balance at end of period at Jun. 30, 2025	$ 1,311,918	$ 102	1,341,843	(30,027)	0
Balance at beginning of period (in shares) at Mar. 31, 2025		102,164,000
Balance at beginning of period at Mar. 31, 2025	1,313,222	$ 102	1,366,786	(53,666)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	40,968				40,968
Other comprehensive income (loss)	23,639			23,639
Dividends declared			(39,473)
Dividends declared	(60,284)				(20,811)
Net issuances of restricted stock (in shares)		36,000
Stock-based compensation	14,530		14,530
Repurchases of common stock (in shares)		(461,000)
Repurchases of common stock	$ (20,157)				(20,157)
Balance at ending of period (in shares) at Jun. 30, 2025	101,738,661	101,739,000
Balance at end of period at Jun. 30, 2025	$ 1,311,918	$ 102	$ 1,341,843	$ (30,027)	$ 0